Psilocybin has been explored as an adjunct to therapy since the 1970s, particularly in cases where traditional approaches like antidepressants or talk therapy have not been effective. While research into its safety and efficacy continues, psilocybin remains a controlled substance in Canada and is not legally available to the general public.
Psilocybin-Assisted Therapy & Its Emerging Potential
Psilocybin-assisted therapy is currently being investigated in clinical trials as a potential approach for individuals experiencing treatment-resistant mental health conditions, including depression and anxiety. In research settings, psilocybin is combined with psychotherapy in carefully controlled environments to explore how it may support psychological insight, emotional processing, and personal transformation.
Participants in studies have described experiences of enhanced self-reflection, increased emotional openness, and a renewed sense of meaning—effects that may support therapeutic outcomes when facilitated by trained professionals.
While psilocybin-assisted therapy is not currently available to the public in Canada, ongoing research continues to inform the evolving landscape of mental health care and psychedelic-assisted therapy.
Clinical studies are examining how psilocybin may support:
- Reduction in depressive symptoms
- Increased emotional insight and awareness
- Alleviation of anxiety in specific contexts
- Support for individuals with existential distress
- Lasting shifts in outlook and well-being
Ready to get started?
As you book an information call, we invite you to review these important considerations. They play a role in determining your eligibility for treatment. Your attention to these questions will help us better understand your needs and supports for your journey.
Learn more about Psilocybin
- How Psilocybin Reduces Symptoms of Depression | Psychology Today
- How Magic Mushrooms Can Fix Depression | Psychology Today
- Psilocybin for Depression: What You Need to Know | verywellmind.com
- Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows | Johns Hopkins Medicine
Schedule a free Information
Call to get started
Disclaimer
Psilocybin has not received approval from Health Canada or the Food and Drug Administration for treating any mental health conditions. This page offers information strictly for educational purposes and does not comprehensively cover the current research on psychedelic treatments, including their effectiveness, contraindications, risks, side effects, or other relevant details. For further information, please refer to our Disclaimers in our Terms of Use.
